ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease In-vitro Diagnostic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24D9888
Home | Market Reports | Health| Medical Devices & Equipment
Global Infectious Disease In vitro Diagnostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Infectious Disease In-vitro Diagnostic Market Research Report 2025

Code: QYRE-Auto-24D9888
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
BioMérieux SA
Abbott
Quidel Corporation
Orasure Technologies, Inc.
Danaher
Qiagen NV
Roche
Siemens Healthineers AG
Bio-Rad Laboratories Inc
Hologic, Inc. (Gen Probe)

Infectious Disease In-vitro Diagnostic Market Size

The global market for Infectious Disease In-vitro Diagnostic was valued at US$ 70.3 million in the year 2024 and is projected to reach a revised size of US$ 91.5 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Infectious Disease In-vitro Diagnostic Market

Infectious Disease In-vitro Diagnostic Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease In-vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease In-vitro Diagnostic.
The Infectious Disease In-vitro Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease In-vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease In-vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease In-vitro Diagnostic Market Report

Report Metric Details
Report Name Infectious Disease In-vitro Diagnostic Market
Accounted market size in year US$ 70.3 million
Forecasted market size in 2031 US$ 91.5 million
CAGR 3.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • COVID-19
  • MRSA
  • Clostridium Difficile
  • Respiratory Virus
  • TB and Drug-resistant TB
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN, Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease In-vitro Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease In-vitro Diagnostic Market growing?

Ans: The Infectious Disease In-vitro Diagnostic Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Infectious Disease In-vitro Diagnostic Market size in 2031?

Ans: The Infectious Disease In-vitro Diagnostic Market size in 2031 will be US$ 91.5 million.

Who are the main players in the Infectious Disease In-vitro Diagnostic Market report?

Ans: The main players in the Infectious Disease In-vitro Diagnostic Market are BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN, Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Inc.

What are the Application segmentation covered in the Infectious Disease In-vitro Diagnostic Market report?

Ans: The Applications covered in the Infectious Disease In-vitro Diagnostic Market report are COVID-19, MRSA, Clostridium Difficile, Respiratory Virus, TB and Drug-resistant TB, Chlamydia, Gonorrhea, HPV, HIV, Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)

What are the Type segmentation covered in the Infectious Disease In-vitro Diagnostic Market report?

Ans: The Types covered in the Infectious Disease In-vitro Diagnostic Market report are Immunoassay, Molecular Diagnostics, Microbiology, Others

Recommended Reports

In-vitro Diagnostics

Infectious Disease

Virus Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Molecular Diagnostics
1.2.4 Microbiology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Infectious Disease In-vitro Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 COVID-19
1.3.3 MRSA
1.3.4 Clostridium Difficile
1.3.5 Respiratory Virus
1.3.6 TB and Drug-resistant TB
1.3.7 Chlamydia
1.3.8 Gonorrhea
1.3.9 HPV
1.3.10 HIV
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease In-vitro Diagnostic Market Perspective (2020-2031)
2.2 Global Infectious Disease In-vitro Diagnostic Growth Trends by Region
2.2.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease In-vitro Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease In-vitro Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease In-vitro Diagnostic Market Dynamics
2.3.1 Infectious Disease In-vitro Diagnostic Industry Trends
2.3.2 Infectious Disease In-vitro Diagnostic Market Drivers
2.3.3 Infectious Disease In-vitro Diagnostic Market Challenges
2.3.4 Infectious Disease In-vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue
3.1.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease In-vitro Diagnostic Revenue
3.4 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease In-vitro Diagnostic Revenue in 2024
3.5 Global Key Players of Infectious Disease In-vitro Diagnostic Head office and Area Served
3.6 Global Key Players of Infectious Disease In-vitro Diagnostic, Product and Application
3.7 Global Key Players of Infectious Disease In-vitro Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease In-vitro Diagnostic Breakdown Data by Type
4.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2026-2031)
5 Infectious Disease In-vitro Diagnostic Breakdown Data by Application
5.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease In-vitro Diagnostic Market Size (2020-2031)
6.2 North America Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025)
6.4 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic Market Size (2020-2031)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025)
7.4 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease In-vitro Diagnostic Market Size (2020-2031)
9.2 Latin America Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Disease In-vitro Diagnostic Introduction
11.1.4 BD Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.1.5 BD Recent Development
11.2 BioMérieux SA
11.2.1 BioMérieux SA Company Details
11.2.2 BioMérieux SA Business Overview
11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Introduction
11.2.4 BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.2.5 BioMérieux SA Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Infectious Disease In-vitro Diagnostic Introduction
11.3.4 Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Quidel Corporation
11.4.1 Quidel Corporation Company Details
11.4.2 Quidel Corporation Business Overview
11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Introduction
11.4.4 Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.4.5 Quidel Corporation Recent Development
11.5 OraSure Technologies, Inc.
11.5.1 OraSure Technologies, Inc. Company Details
11.5.2 OraSure Technologies, Inc. Business Overview
11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.5.4 OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.5.5 OraSure Technologies, Inc. Recent Development
11.6 Hologic, Inc. (Gen Probe)
11.6.1 Hologic, Inc. (Gen Probe) Company Details
11.6.2 Hologic, Inc. (Gen Probe) Business Overview
11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Introduction
11.6.4 Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.6.5 Hologic, Inc. (Gen Probe) Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Infectious Disease In-vitro Diagnostic Introduction
11.7.4 Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.7.5 Danaher Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Introduction
11.8.4 QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.8.5 QIAGEN Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Infectious Disease In-vitro Diagnostic Introduction
11.9.4 Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.9.5 Roche Recent Development
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Details
11.10.2 Siemens Healthineers AG Business Overview
11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Introduction
11.10.4 Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.10.5 Siemens Healthineers AG Recent Development
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Details
11.11.2 Bio-Rad Laboratories, Inc. Business Overview
11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.11.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025)
11.11.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
BD
BioMérieux SA
Abbott
Quidel Corporation
Orasure Technologies, Inc.
Danaher
Qiagen NV
Roche
Siemens Healthineers AG
Bio-Rad Laboratories Inc
Hologic, Inc. (Gen Probe)
List of Tables
 Table 1. Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunoassay
 Table 3. Key Players of Molecular Diagnostics
 Table 4. Key Players of Microbiology
 Table 5. Key Players of Others
 Table 6. Global Infectious Disease In-vitro Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Infectious Disease In-vitro Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Infectious Disease In-vitro Diagnostic Market Share by Region (2020-2025)
 Table 10. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Infectious Disease In-vitro Diagnostic Market Share by Region (2026-2031)
 Table 12. Infectious Disease In-vitro Diagnostic Market Trends
 Table 13. Infectious Disease In-vitro Diagnostic Market Drivers
 Table 14. Infectious Disease In-vitro Diagnostic Market Challenges
 Table 15. Infectious Disease In-vitro Diagnostic Market Restraints
 Table 16. Global Infectious Disease In-vitro Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Infectious Disease In-vitro Diagnostic Market Share by Players (2020-2025)
 Table 18. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2024)
 Table 19. Ranking of Global Top Infectious Disease In-vitro Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Infectious Disease In-vitro Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Infectious Disease In-vitro Diagnostic, Headquarters and Area Served
 Table 22. Global Key Players of Infectious Disease In-vitro Diagnostic, Product and Application
 Table 23. Global Key Players of Infectious Disease In-vitro Diagnostic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Infectious Disease In-vitro Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2020-2025)
 Table 27. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2026-2031)
 Table 29. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2020-2025)
 Table 31. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2026-2031)
 Table 33. North America Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. BD Company Details
 Table 49. BD Business Overview
 Table 50. BD Infectious Disease In-vitro Diagnostic Product
 Table 51. BD Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 52. BD Recent Development
 Table 53. BioMérieux SA Company Details
 Table 54. BioMérieux SA Business Overview
 Table 55. BioMérieux SA Infectious Disease In-vitro Diagnostic Product
 Table 56. BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 57. BioMérieux SA Recent Development
 Table 58. Abbott Company Details
 Table 59. Abbott Business Overview
 Table 60. Abbott Infectious Disease In-vitro Diagnostic Product
 Table 61. Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 62. Abbott Recent Development
 Table 63. Quidel Corporation Company Details
 Table 64. Quidel Corporation Business Overview
 Table 65. Quidel Corporation Infectious Disease In-vitro Diagnostic Product
 Table 66. Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 67. Quidel Corporation Recent Development
 Table 68. OraSure Technologies, Inc. Company Details
 Table 69. OraSure Technologies, Inc. Business Overview
 Table 70. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product
 Table 71. OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 72. OraSure Technologies, Inc. Recent Development
 Table 73. Hologic, Inc. (Gen Probe) Company Details
 Table 74. Hologic, Inc. (Gen Probe) Business Overview
 Table 75. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product
 Table 76. Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 77. Hologic, Inc. (Gen Probe) Recent Development
 Table 78. Danaher Company Details
 Table 79. Danaher Business Overview
 Table 80. Danaher Infectious Disease In-vitro Diagnostic Product
 Table 81. Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 82. Danaher Recent Development
 Table 83. QIAGEN Company Details
 Table 84. QIAGEN Business Overview
 Table 85. QIAGEN Infectious Disease In-vitro Diagnostic Product
 Table 86. QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 87. QIAGEN Recent Development
 Table 88. Roche Company Details
 Table 89. Roche Business Overview
 Table 90. Roche Infectious Disease In-vitro Diagnostic Product
 Table 91. Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 92. Roche Recent Development
 Table 93. Siemens Healthineers AG Company Details
 Table 94. Siemens Healthineers AG Business Overview
 Table 95. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product
 Table 96. Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 97. Siemens Healthineers AG Recent Development
 Table 98. Bio-Rad Laboratories, Inc. Company Details
 Table 99. Bio-Rad Laboratories, Inc. Business Overview
 Table 100. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product
 Table 101. Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 102. Bio-Rad Laboratories, Inc. Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease In-vitro Diagnostic Picture
 Figure 2. Global Infectious Disease In-vitro Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease In-vitro Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Immunoassay Features
 Figure 5. Molecular Diagnostics Features
 Figure 6. Microbiology Features
 Figure 7. Others Features
 Figure 8. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Infectious Disease In-vitro Diagnostic Market Share by Application: 2024 VS 2031
 Figure 10. COVID-19 Case Studies
 Figure 11. MRSA Case Studies
 Figure 12. Clostridium Difficile Case Studies
 Figure 13. Respiratory Virus Case Studies
 Figure 14. TB and Drug-resistant TB Case Studies
 Figure 15. Chlamydia Case Studies
 Figure 16. Gonorrhea Case Studies
 Figure 17. HPV Case Studies
 Figure 18. HIV Case Studies
 Figure 19. Infectious Disease In-vitro Diagnostic Report Years Considered
 Figure 20. Global Infectious Disease In-vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Infectious Disease In-vitro Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Infectious Disease In-vitro Diagnostic Market Share by Region: 2024 VS 2031
 Figure 23. Global Infectious Disease In-vitro Diagnostic Market Share by Players in 2024
 Figure 24. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2024)
 Figure 25. The Top 10 and 5 Players Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2024
 Figure 26. North America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Infectious Disease In-vitro Diagnostic Market Share by Country (2020-2031)
 Figure 28. United States Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Infectious Disease In-vitro Diagnostic Market Share by Country (2020-2031)
 Figure 32. Germany Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Share by Region (2020-2031)
 Figure 40. China Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Infectious Disease In-vitro Diagnostic Market Share by Country (2020-2031)
 Figure 48. Mexico Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Share by Country (2020-2031)
 Figure 52. Turkey Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. BD Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 56. BioMérieux SA Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 57. Abbott Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 58. Quidel Corporation Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 59. OraSure Technologies, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 60. Hologic, Inc. (Gen Probe) Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 61. Danaher Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 62. QIAGEN Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 63. Roche Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 64. Siemens Healthineers AG Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 65. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024
Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025
In Vitro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vitro Diagnostics Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025
In Vitro Diagnostics Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Diagnostic and Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Clinical Diagnostic System Market Research Report 2024
Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Electro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aquaculture Bacterial Diagnosis Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions